These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36472166)

  • 1. Ferrocene-liposome-PEG: a robust ˙OH/lipid peroxide nano-converter for inducing tumor ferroptosis.
    Liu Y; Chen J; He Z; Luo H; Liu X; Sun Y; Ge D; Liu X; Shi W
    Biomater Sci; 2023 Jan; 11(2):542-553. PubMed ID: 36472166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsaturated phospholipid modified FeOCl nanosheets for enhancing tumor ferroptosis.
    He Z; Guo Y; Chen J; Luo H; Liu X; Zhang X; Sun Y; Ge D; Ye S; Shi W
    J Mater Chem B; 2023 Mar; 11(9):1891-1903. PubMed ID: 36744515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activatable unsaturated liposomes increase lipid peroxide of cell membrane and inhibit tumor growth.
    Fu JJ; Liu CC; Feng GN; Li SP; Yu YY; Du LR; Zhang JY; Zhang Y; Lei XP; Dai X; Yu XY
    Biomater Adv; 2023 Apr; 147():213323. PubMed ID: 36764198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes embedded with PEGylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer.
    Liu Y; Quan X; Li J; Huo J; Li X; Zhao Z; Li S; Wan J; Li J; Liu S; Wang T; Zhang X; Guan B; Wen R; Zhao Z; Wang C; Bai C
    Natl Sci Rev; 2023 Jan; 10(1):nwac167. PubMed ID: 36684514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
    Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
    Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
    Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
    Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
    He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
    Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-Active Ferrocene Quencher-Based Supramolecular Nanomedicine for NIR-II Fluorescence-Monitored Chemodynamic Therapy.
    Yu M; Ye Z; Liu S; Zhu Y; Niu X; Wang J; Ao R; Huang H; Cai H; Liu Y; Chen X; Lin L
    Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202318155. PubMed ID: 38109458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H
    Zhu XY; Wang TY; Jia HR; Wu SY; Gao CZ; Li YH; Zhang X; Shan BH; Wu FG
    J Control Release; 2024 Mar; 367():892-904. PubMed ID: 38278369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy.
    Wang Y; Zhang S; Wang J; Zhou Q; Mukerabigwi JF; Ke W; Lu N; Ge Z
    J Control Release; 2021 May; 333():500-510. PubMed ID: 33848558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells.
    Chen C; Tan Y; Xu T; Sun Y; Zhao S; Ouyang Y; Chen Y; He L; Liu X; Liu H
    Langmuir; 2022 Oct; 38(40):12307-12315. PubMed ID: 36154182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Ferrocene-Functionalized Covalent Organic Framework for Enhancing Chemodynamic Therapy via Redox Dyshomeostasis.
    Zhou LL; Guan Q; Li WY; Zhang Z; Li YA; Dong YB
    Small; 2021 Aug; 17(32):e2101368. PubMed ID: 34216420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrocene and glucose oxidase-installed multifunctional hydrogel reactors for local cancer therapy.
    Lee SY; Park J; Jeong DI; Hwang C; Lee J; Lee K; Kim HJ; Cho HJ
    J Control Release; 2022 Sep; 349():617-633. PubMed ID: 35868357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-acidity and bioorthogonal chemistry-mediated construction and deconstruction of drug depots for ferroptosis under normoxia and hypoxia.
    Zhou J; Wang K; Jiang M; Li J; Yuan Y
    Acta Biomater; 2022 Apr; 142():253-263. PubMed ID: 35085800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
    Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
    Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang X; Ding Y; Zhang Z; Ma Y; Sun X; Wang L; Yang Z; Hu ZW
    Nano Lett; 2023 Aug; 23(16):7665-7674. PubMed ID: 37535903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.